Join
Live feed
·
NEWSReleasevia Quantisnow
Eucrates Biomedical Acquisition Corp. logo

Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EUCR (Eucrates Biomedical Acquisition Corp.) and more on Quantisnow.